<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Declarations</title>
 <notes id="FPar2" notes-type="funding">
  <title>Funding</title>
  <p id="Par118">Tanja Peters: funding for this research included working hours dedicated to this research remunerated by Boehringer Ingelheim as part of salary. No additional sources of funding were stated by the authors as being used to assist in the preparation of this study.</p>
 </notes>
 <notes id="FPar3" notes-type="COI-statement">
  <title>Conflict of interest</title>
  <p id="Par119">Tanja Peters was employed at Boehringer Ingelheim at the time this research was completed. As of April 1, 2020, Tanja Peters is an employee of Merck Healthcare KGaA and owns stocks of Merck KGaA. Tanja Peters also conducts ancillary work with the Forum Institute for Professional Training in Heidelberg, Germany. Nigel Soanes is employed by AstraZeneca and has reported no additional conflicts of interest. Maya Abbas is employed by Johnson &amp; Johnson Middle East and declares that she has no conflict of interest. Jabeen Ahmad was previously employed by AbbVie and Innovate PV during the writing of the manuscript. Jabeen is now employed by Roche and has reported no conflicts of interest. Jean-Christophe Delumeau is employed by Bayer, serving 
   <italic>pro bono</italic> the International Society of Pharmacovigilance as a board and executive committee member. He has not reported additional conflicts of interest. Esteban Herrero-Martinez is employed by AbbVie and has reported no additional conflicts of interest. MÃ©lanie Paramananda is employed by Pierre Fabre and has reported no additional conflicts of interest. Johanna Piper is employed by Roche Products Ltd and has reported no additional conflicts of interest. Fairouz Smail-Aoudia is employed by Pierre Fabre and has reported no additional conflicts of interest. Willemijn van der Spuij is employed by Bristol Myers Squibb and has reported no additional conflicts of interest. Tina Veizovic is employed by Takeda and has reported no additional conflicts of interest. Gillian Winstanley is employed by Amgen Canada Inc. and has reported no additional conflicts of interest.
  </p>
 </notes>
 <notes id="FPar4">
  <title>Ethics approval</title>
  <p id="Par120">Not applicable, as this article does not refer to data relative to individuals.</p>
 </notes>
 <notes id="FPar5">
  <title>Consent to participate</title>
  <p id="Par121">Not applicable, as this article does not refer to data relative to individuals.</p>
 </notes>
 <notes id="FPar6">
  <title>Consent for publication</title>
  <p id="Par122">Not applicable, as this article does not refer to data relative to individuals.</p>
 </notes>
 <notes id="FPar7">
  <title>Availability of data and materials</title>
  <p id="Par123">Data sharing is not applicable to this article as no datasets were generated or analysed during the current study. The materials referred to in this article consist of guidelines and legislation publicly available on the websites of the respective institutions.</p>
 </notes>
 <notes id="FPar8">
  <title>Code availability</title>
  <p id="Par124">Not applicable, as no computer system was used for data compilation or analysis.</p>
 </notes>
 <notes id="FPar9" notes-type="author-contribution">
  <title>Author contributions</title>
  <p id="Par125">All authors contributed to the conception and writing of the review. All Authors read and approved the manuscript.</p>
 </notes>
</notes>
